News
7h
The Nation UAE on MSNFBR has power to assess tax liability on high-value intra-group transaction: IHCThursday upheld the powers and jurisdiction of the Federal Board of Revenue (FBR) in assessing tax liability on a high-value intra-group transaction involving the transfer of Telecom Operator's tower ...
Dubai Abu Dhabi‑based IHC, in collaboration with BlackRock and Lunate, has officially launched Reinsurance Intelligence ...
Immaculate Heart Central seniors Abigail Bombard and Samuel Charlebois were named recipients of the Clarence "Boots" Gaffney Award, IHC, the Italian-American Civic Association and the Northern New ...
ISLAMABAD: The Federal Board of Revenue (FBR) is apparently ill-prepared in recovery of billions of rupees stuck in the litigation as its focal persons assigned to coordinate with the Islamabad High ...
ISLAMABAD: The Islamabad High Court (IHC) on Thursday intervened to stop the Federal Investigation Agency (FIA) from ...
Boots” Gaffney Award. IHC seniors Abigail Bombard and Samuel Charlebois were given the prestigious honor from the ...
IHC launches RIQ, a next-gen AI-driven reinsurance platform based in Abu Dhabi’s ADGM, backed by $1bn and supported by ...
Global investment firm IHC has announced the official launch of Reinsurance Intelligence Quotient (RIQ), the newly named ...
Artificial intelligence (AI)-assisted training improves pathologist accuracy in human epidermal growth factor receptor 2 (HER2) immunohistochemistry (IHC) scoring in patients with breast cancer.
2d
The Nation UAE on MSNIHC defers hearing of appeals in £190m case againWednesday again deferred hearing of the PTI founder Imran Khan and his spouse Bushra Bibi's appeals seeking suspension of their sentence in 190 million pound case. A two-member bench of IHC comprising ...
View the full release here: "This partnership is both a privilege and a milestone for BigBear.ai. It is a powerful endorsement of our technology and values," said Kevin McAleenan, CEO of BigBear.ai.
A training platform integrated with AI can help pathologists identify HER2-low and HER2-ultralow breast cancers with more accuracy, data suggest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results